Share Twitter LinkedIn Facebook Email Joan Schiller, MD, talks about the Keynote trials presented and whether they will impact her choice of therapy for squamous or non-squamous lung cancer patients at the Annual Meeting 2018 Annual Meeting. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read